Asian Spectator

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

  • Written by ACN Newswire - Press Releases

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

SHANGHAI, CHINA, Jul 20, 2020 - (ACN Newswire) - Antengene Corporation, a leading innovative hematology and oncology-focused biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and best-in-class therapies, today announced that it has successfully closed US$97 million in Series C financing.

The...

More Articles ...

  1. Top 7 Benefits That a CBD-Rich Oil Can Potentially Offer
  2. Australians concerned about their financial wellbeing as a result of COVID-19
  3. Fivetran Raises $100 Million to Accelerate Growth as Automated Data Integration Leader
  4. Commodities Intelligence Centre (CIC) introduces international Trade Data and Business Services, partners SBF to drive digital transformation of Singapore SMEs

Magazine

Sindrom kepala meledak: bikin mendadak melek karena dengar suara keras

Sindrom kepala meledak merupakan gangguan tidur yang belum diketahui penyebabnya.Ad Gr/ShutterstockPernahkah kamu berada di situasi nyaris tertidur, lalu mendadak terjaga karena mendengar suara ledaka...

Bisakah program makan bergizi gratis atasi ‘stunting’ di Indonesia?

Prabowo-Gibran yang pencalonannya sebagai Presiden dan Wakil Presiden memantik kontroversi akan bekerja mulai 20 Oktober 2024.Untuk mengawal pemerintahan mereka, kami menerbitkan edisi khusus #PantauP...

Bisakah mata uang kripto ramah lingkungan?

Mabeline72/ShutterstockMata uang kripto kerap dikritik karena minimnya kontribusi terhadap lingkungan di saat kegiatan investasi tradisional beralih ke nilai lingkungan, sosial, dan tata kelola (ESG) ...



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion